GE Healthcare wins Market Leadership Award for PET-CT business
30 March 2005. PALO ALTO, Calif., USA. Frost & Sullivan's has selected GE
Healthcare as the recipient of the 2004 Market Leadership Award in the
PET-CT market. This award acknowledges the company's exceptional marketing
strategies that helped it capture the largest percentage of the U.S.
positron emission tomography-computed tomography (PET-CT) market in 2003 and
maintain its robust lead since the market's inception.
Every year, Frost & Sullivan presents this award to the company that has
substantially increased its market share by implementing innovative market
engineering strategies in the PET-CT market. The company has also identified
industry challenges and market drivers and restraints, and used this
knowledge to establish itself as a market leader.
"GE Healthcare established an early lead in the PET-CT market by
incorporating impeccable operations management and unmatched product
delivery times to meet customers' needs," says Frost & Sullivan Industry
Research Manager Antonio Garcia. "Within a year after entering the PET-CT
market, the company quickly established itself as the clear leader in
PET-CT, capturing nearly three-quarters of the market by the end of 2002."
"GE Healthcare's undisputed mastery in the areas of operations management
and logistics has enabled the company to design, build, and deliver its
products faster than the competition," notes Garcia. "This factor has
undoubtedly played a major role in raising the bar for all participants in
the PET-CT market."
GE Healthcare launched a personalized healthcare initiative in 2004,
installing four research units at sites such as John's Hopkins and the
University Hospital in Zurich, Switzerland. These units are expected to
generate data that will broaden PET/CT technology application beyond cancer
The company is likely to extend its market leadership into 2005 and 2006
as double-digit growth rates are expected in unit shipments and revenue. GE
Healthcare will continue to leverage its exceptional marketing efforts and
unparalleled brand equity by delivering life-saving technology that helps
doctors diagnose, manage and treat an individual's medical condition earlier